검색어 : 통합검색[Laird Michael]
총 786건 중 786건 출력
, 56/79 페이지
-
551
- Neoadjuvant talazoparib in patients with germline BRCA1/2 mutation-positive, early-stage triple-negative breast cancer: exploration of tumor BRCA mutational status
- Telli, Melinda L.; Litton, Jennifer K.; Beck, J. Thaddeus; Jones, Jason M.; Andersen, Jay; Mina, Lida A.; Brig, Raymond; Danso, Michael; Yuan; Symmans, William F.; Hopkins, Julia F.; Albacker, Lee A.; Abbattista, Antonello; Noonan, Kay; Mata, Marielena; Laird, A. Douglas; Blum, Joanne L.; ; (Breast cancer : the journal of the Japanese Breast Cancer Society, v.31, 2024, pp.886-897)
-
552
- HIV-Induced Modulation of TREM2 Expression Is Reversed by Cannabidiol: Implications for Age-Related Neuropathogenesis in People with HIV
- Avalos Bryant; Kulbe Jacqueline R; Ford Mary; Laird Anna Elizabeth; Walter Kyle; Mante Michael; Florio Jazmin; Boustani Ali; Chaillon Antoine; Schlachetzki Johannes; Sundermann Erin; Volsky David; Rissman Robert A; Ellis Ronald; Letendre Scott; Iudicello Jennifer; Fields Jerel Adam; ; (, v., 2024, )
-
553
- Speckle nulling wavefront control for Palomar and Keck
- Marchetti, Enrico; Close, Laird M.; Vé ran, Jean-Pierre; Bottom, Michael; Femenia, Bruno; Huby, Elsa; Mawet, Dimitri; Dekany, Richard; Milburn, Jennifer; Serabyn, Eugene; European Southern Observatory (Germany); The Univ. of Arizona (United States); National Research Council Canada (Canada); California Institute of Technology (United States); W.M. Keck Observatory (United States); Univ. de Liè ge (Belgium); California Institute of Technology (United States); California Institute of Technology (United States); California Institute of Technology (United States); Jet Propulsion Lab. (United States); (Adaptive Optics Systems V, v.9909, 2016, pp.990955)
-
554
- Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth
- Yakes, F. Michael; Chen, Jason; Tan, Jenny; Yamaguchi, Kyoko; Shi, Yongchang; Yu, Peiwen; Qian, Fawn; Chu, Felix; Bentzien, Frauke; Cancilla, Belinda; Orf, Jessica; You, Andrew; Laird, A. Douglas; Engst, Stefan; Lee, Lillian; Lesch, Justin; Chou, Yu-Chien; Joly, Alison H.; Authors' Affiliation: Exelixis, Inc., South San Francisco, California; Authors' Affiliation: Exelixis, Inc., South San Francisco, California; Authors' Affiliation: Exelixis, Inc., South San Francisco, California; Authors' Affiliation: Exelixis, Inc., South San Francisco, California; Authors' Affiliation: Exelixis, Inc., South San Francisco, California; Authors' Affiliation: Exelixis, Inc., South San Francisco, California; Authors' Affiliation: Exelixis, Inc., South San Francisco, California; Authors' Affiliation: Exelixis, Inc., South San Francisco, California; Authors' Affiliation: Exelixis, Inc., South San Francisco, California; Authors' Affiliation: Exelixis, Inc., South San Francisco, California; Authors' Affiliation: Exelixis, Inc., South San Francisco, California; Authors' Affiliation: Exelixis, Inc., South San Francisco, California; Authors' Affiliation: Exelixis, Inc., South San Francisco, California; Authors' Affiliation: Exelixis, Inc., South San Francisco, Calif; (Molecular cancer therapeutics, v.10, 2011, pp.2298-2308)
-
555
- Sunitinib Treatment Exacerbates Intratumoral Heterogeneity in Metastatic Renal Cancer
- Stewart, Grant D.; O'Mahony, Fiach C.; Laird, Alexander; Eory, Lel; Lubbock, Alexander L.R.; Mackay, Alan; Nanda, Jyoti; O'Donnell, Marie; Mullen, Peter; McNeill, S. Alan; Riddick, Antony C.P.; Berney, Daniel; Bex, Axel; Aitchison, Michael; Overton, Ian M.; Harrison, David J.; Powles, Thomas; Edinburgh Urological Cancer Group, Division of Pathology, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom.; Edinburgh Urological Cancer Group, Division of Pathology, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom.; Edinburgh Urological Cancer Group, Division of Pathology, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom.; MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom.; MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom.; Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Belmont, Sutton, Surrey, United Kingdom.; Edinburgh Urological Cancer Group, Division of Pathology, Institute of Genetics and Molecular Medicine, University of Edinb; (Clinical Cancer research : an official journal of the American Association for Cancer Research, v.21, 2015, pp.4212-4223)
-
556
- X chromosome associations with chronic obstructive pulmonary disease and related phenotypes: an X chromosome-wide association study
- Hayden, Lystra P.; Hobbs, Brian D.; Busch, Robert; Cho, Michael H.; Liu, Ming; Lopes-Ramos, Camila M.; Lomas, David A.; Bakke, Per; Gulsvik, Amund; Silverman, Edwin K.; Crapo, James D.; Beaty, Terri H.; Laird, Nan M.; Lange, Christoph; DeMeo, Dawn L.; Division of Pulmonary Medicine, Boston Children’s Hospital, Harvard Medical School, Boston, MA USA; Channing Division of Network Medicine, Brigham and Women’s Hospital, Harvard Medical School, 181 Longwood Ave, Boston, MA 02115 USA; Division of Pulmonology, Allergy, and Critical Care, U.S. Food and Drug Administration, Silver Spring, MD USA; Channing Division of Network Medicine, Brigham and Women’s Hospital, Harvard Medical School, 181 Longwood Ave, Boston, MA 02115 USA; Bioinformatics and Computational Biology Program, Worcester Polytechnic Institute, Worcester, MA USA; Channing Division of Network Medicine, Brigham and Women’s Hospital, Harvard Medical School, 181 Longwood Ave, Boston, MA 02115 USA; UCL Respiratory, University College London, London, UK; Department of Clinical Science, University of Bergen, Bergen, Norway; Department of Clinical Science, University of Bergen, Bergen, Norway; Channing Division of Network Medicine, Brigham and Women’s Hospital, Harv; (Respiratory research, v.24, 2023, pp.38)
-
557
- Proteomic analysis of pre- and post-sunitinib treated renal cancer tissue to assess tumor heterogeneity and differential protein expression.
- Stewart, Grant Duncan; O'Mahony, Fiach; Eory, Lel; Nanda, Jyoti; Laird, Alexander; O'Donnell, Marie; Mullen, Peter; Riddick, Antony; McNeill, Alan; Aitchison, Michael; Berney, Dan; Peters, John; Rockall, Andrea; Sahdev, Anju; Bex, Axel; Faratian, Dana; Chowdhury, Simon; Harrison, David; Overton, Ian; Powles, Thomas; University of Edinburgh, Edinburgh, United Kingdom; MRC Human Genetics Unit, Edinburgh, United Kingdom; The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom; Department of Histopathology, St. Bartholomew's Hospital, London, United Kingdom; Whipps Cross Hospital, London, United Kingdom; St. Bartholomew's Hospital, London, United Kingdom; The Netherlands Cancer Institute, Amsterdam, Netherlands; Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom; University of Edinburgh, Edinburgh, United Kingdom; MRC Human Genetics Unit, Edinburgh, United Kingdom; The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom; Department of Histopathology, St. Bartholomew's Hospital, London, United Kingdom; Whipps Cross Hospital, London, United Kingdom; St. Bartholomew's Hospital, London, United Kingdom; The Netherlands Cancer Institute, Amsterdam, Netherlands; Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom; University of Edinburgh, Edinburgh, Un; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.30, 2012, pp.388-388)
-
558
- Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome
- Cortes, Jorge E.; Heidel, Florian H.; Hellmann, Andrzej; Fiedler, Walter; Smith, B. Douglas; Robak, Tadeusz; Montesinos, Pau; Pollyea, Daniel A.; DesJardins, Pierre; Ottmann, Oliver; Ma, Weidong Wendy; Shaik, M. Naveed; Laird, A. Douglas; Zeremski, Mirjana; O’Connell, Ashleigh; Chan, Geoffrey; Heuser, Michael; Department of Leukemia, University of Texas, MD Anderson Cancer Center,; Otto-von-Guericke University Medical Center,; Department of Haematology and Transplantology, Medical University of Gdań sk,; Department of Hematology and Oncology, University Hospital Hamburg-Eppendorf,; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center,; Department of Hematology, Medical University of Lodz,; Hospital Universitari i Politè cnic La Fe,; Division of Hematology, University of Colorado School of Medicine,; Hô pital Charles LeMoyne,; Division of Cancer and Genetics, School of Medicine, Cardiff University,; Pfizer Oncology,; Pfizer Oncology,; Pfizer Oncology,; Pfizer Oncology,; Pfizer Oncology,; Pfizer Oncology,; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School,; (Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K, v.33, 2019, pp.379-389)
-
559
- Single-Cell Analysis of Senescent Epithelia Reveals Targetable Mechanisms Promoting Fibrosis : PO0643
- Sullivan, Eoin D. O; Mylonas, Katie J.; Carvalho, Cyril; Docherty, Marie; Cairns, Carolynn; Gallagher, Kevin M.; Laird, Alexander; Henderson, Neil; Chandra, Tamir; Kirschner, Kristina; Conway, Bryan; Denby, Laura; Dihazi, Gry H.; Zeisberg, Michael; Hughes, Jeremy; Dihazi, Hassan; Ferenbach, David A.; The University of Edinburgh Centre for Inflammation Research, Edinburgh, United Kingdom; ; The University of Edinburgh Centre for Inflammation Research, Edinburgh, United Kingdom; ; The University of Edinburgh Centre for Inflammation Research, Edinburgh, United Kingdom; ; The University of Edinburgh Centre for Inflammation Research, Edinburgh, United Kingdom; ; The University of Edinburgh Centre for Cardiovascular Science, Edinburgh, United Kingdom; ; Western General Hospital, Edinburgh, United Kingdom; ; Western General Hospital, Edinburgh, United Kingdom; ; The University of Edinburgh MRC Human Genetics Unit, Edinburgh, United Kingdom.; The University of Edinburgh MRC Human Genetics Unit, Edinburgh, United Kingdom.; University of Glasgow Institute of Cancer Sciences, Glasgow, United Kingdom; ; The University of Edinburgh Centre for Cardiovascular Science, Edinburgh, United Kingdom; ; The University of Edinburgh Centre for Cardiovascular Science, Edinburgh, United Kingdom; ; Georg-A; (Journal of the American Society of Nephrology : JASN, v.32, 2021, pp.236-236)
-
560
- Erlotinib or Gefitinib for Treating Advanced Epidermal Growth Factor Receptor Mutation–Positive Lung Cancer in Aotearoa New Zealand: Protocol for a National Whole-of-Patient-Population Retrospective Cohort Study and Results of a Validation Substudy (Preprint)
- Aye Phyu Sin; Barnes Joanne; Laking George; Cameron Laird; Anderson Malcolm; Luey Brendan; Delany Stephen; Harris Dean; McLaren Blair; Brenman Elliott; Wong Jayden; Lawrenson Ross; Arendse Michael; Tin Tin Sandar; Elwood Mark; Hope Philip; McKeage Mark James; ; (, v., 2023, )
QUICK MENU
